Hong Kong biotech firm Prenetics is set to list on the Nasdaq through a SPAC merger

Name: Hong Kong biotech firm Prenetics is set to list on the Nasdaq through a SPAC merger
Uploaded: 2021-07-16T01:34:10.000Z
Duration: 1 min 50 s
Description: Hong Kong biotech Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, a source tells CNBC's Emily Tan. The deal will value the new entity at $1.3 billion or more, and is expected to close by year's end.

Hong Kong biotech Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, a source tells CNBC's Emily Tan. The deal will value the new entity at $1.3 billion or more, and is expected to close by year's end.

01:50

Thu, Jul 15 20219:34 PM EDT

nd 2021 revenue is projected to surpass $200 million